Expression of retinoid X receptor beta is induced in astrocytes during corpus callosum demyelination

Journal of Chemical Neuroanatomy

Volumn 43, Issue 2, 2012, Pages 120-132

  König, René ^a   Stillfried, Milena ^a   Aperdannier, Philipp ^a   Clarner, Tim ^b   Beyer, Cordian ^b   Kipp, Markus ^b   Mey, Jörg ^a,c,d  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

^d EURON Graduate School of Neuroscience   (Netherlands)

Author keywords

Astrocyte; Cuprizone; Myelin; Nuclear receptor; Oligodendrocyte; Retinoic acid

Indexed keywords

CELL NUCLEUS RECEPTOR; CUPRIZONE; MYELIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINAL DEHYDROGENASE; RETINOIC ACID; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; BASAL GANGLION; BRAIN CORTEX; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATING DISEASE; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; OLIGODENDROGLIA; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ASTROCYTES; CORPUS CALLOSUM; CUPRIZONE; DEMYELINATING DISEASES; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; RETINOID X RECEPTOR BETA; UP-REGULATION;

EID: 84860358520     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2012.01.002     Document Type: Article

References (67)

1. Agudo M., Yip P., Davies M., Bradbury E., Doherty P., McMahon S., Maden M., Corcoran J.P. A retinoic acid receptor beta agonist (CD2019) overcomes inhibition of axonal outgrowth via phosphoinositide 3-kinase signalling in the injured adult spinal cord. Neurobiol. Dis. 2010, 37:147-155.
2. Andersson S., Gustafsson N., Warner M., Gustafsson J.A. Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:3857-3862.
3. Blomhoff R., Blomhoff H.K. Overview of retinoid metabolism and function. J. Neurobiol. 2006, 66:606-630.
4. Chen N., Napoli J.L. All-trans-retinoic acid stimulates translation and induces spine formation in hippocampal neurons through a membrane-associated RARα. FASEB J. 2008, 22:236-245.
5. Chiang M.-Y., Misner D., Kempermann G., Schikorski T., Giguère V., Sucov H.M., Gage F.H., Stevens C.F., Evans R.M. An essential role for retinoid receptors RARβ and RXRγ in long-term potentiation and depression. Neuron 1998, 21:1353-1361.
6. Choi W.-H., Ji K.-A., Jeon S.-B., Yang M.-S., Kim H., Min K., Shong M., Jou I., Joe E.-H. Anti-inflammatory roles of retinoic acid in rat brain astrocytes: suppression of interferon-γ-induced JAK/STAT phosphorylation. Biochem. Biophys. Res. Commun. 2005, 329:125-131.
7. Cui G., Qin X., Wu L., Zhang Y., Sheng X., Yu Q., Sheng H., Xi B., Zhang J.Z., Zang Y.Q. Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J. Clin. Invest. 2011, 121:658-670.
8. Diab A., Hussai R.Z., Lovett-Racke A.E., Chavis J.A., Drew P.D., Racke M.K. Ligands for the peroxisome proliferator-activated receptor-g and retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmuno encephalomyelitis. J. Immunol. 2004, 148:116-126.
9. Donmez G., Wang D., Cohen D.E., Guarente L. SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 2010, 142:320-332.
10. Feinstein D.L., Galea E., Gavrilyuk V., Brosman C.F., Whitacre C.C., Dumitrescu-Ozimek L., Landreth G.E., Pershadsingh H.A., Weinberg G., Heneka M.T. Peroxisome proliferator-activated receptor-g agonists prefent experimental autoimmune encephalomyelitis. Ann. Neurol. 2002, 51:694-702.
11. Galter D., Buervenich S., Carmine A., Anvret M., Olson E.N. Differences in cytosolic aldehyde dehydrogenase (ALDH1) expression in dopamine neurons of Parkinsons disease and schizophrenia patients and control subjects. Neurobiol. Dis. 2003, 14:637-647.
12. Haskell G.T., Maynard T.M., Shatzmiller R.A., LaMantia A.-S. Retinoic acid signaling at sites of plasticity in the mature central nervous system. J. Comp. Neurol. 2002, 452:228-241.
13. Heck S., Enz R., Richter-Landsberg C., Blohm D.H. Expression of eight metabotropic glutamate receptor subtypes during neuronal differentiation of P19 embryocarcinoma cells: a study by RT-PCR and in situ hybridization. Brain Res. Dev. Brain Res. 1997, 101:85-91.
14. Huang J.K., Jarjour A.A., Oumesmar B.N., Kerninon C., Williams A., Krezel W., Kagechika H., Bauer J., Zhao C., Baron-Van Evercooren A., Chambon P., ffrench-Constant C., Franklin R.J.M. Retinoid X receptor gamma signaling accelerates CNS myelination. Nat. Neurosci. 2011, 14:45-53.
15. Jiang C., Ting A.T., Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391:82-86.
16. Jokic N., Ling Y.Y., Ward R.E., Michael-Titus A.T., Priestley J.V., Malaspina A. Retinoid receptors in chronic degeneration of the spinal cord: observations in a rat model of amyotrophic lateral sclerosis. J. Neurochem. 2007, 103:1821-1833.
17. Kampmann E., Johann S., van Neerven S., Beyer C., Mey J. Anti-inflammatory effect of retinoic acid on prostaglandin synthesis in cultured cortical astrocytes. J. Neurochem. 2008, 106:320-332.
18. Kane M.A., Chen N., Sparks S., Napoli J.L. Quantification of endogenous retinoic acid in limited biological samples by LC/MS/MS. Biochem. J. 2005, 388:363-369.
19. Kastner P., Mark M., Leid M., Gansmuller A., Chin W., Grondona J.M., Decimo D., Krezel W., Dierich A., Chambon P. Abnormal spermatogenesis in RXR beta mutant mice. Genes Dev. 1996, 10:80-92.
20. Kern J., Schrage K., Koopmans G.C., Joosten E.A., McCaffery P., Mey J. Characterization of retinaldehyde dehydrogenase-2 induction in NG2-positive glia after spinal cord contusion injury. Int. J. Dev. Neurosci. 2007, 25:7-16.
21. Kiaei M., Kipiani K., Chen J., Calingasan N.Y., Beal M.F. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 2005, 191:331-336.
22. Kipp M., Gingele S., Pott F., Clarner T., van d., Denecke V., Gan B., Siffrin L., Zipp V., Dreher F., Baumgartner W., Pfeifenbring W., Godbout S., Amor R., Beyer S.C. BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesions. Brain Behav. Immun. 2011, 25:1554-1568.
23. Kliewer S.A., Lenhard J.M., Willson T.M., Patel I., Morris D.C., Lehmann J.M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995, 83:813-819.
24. Környei Z., Gócza E., Rühl R., Orsolits B., Vörös E., Szabó B., Vágovits B., Madarász E. Astroglia-derived retinoic acid is a key factor in glia-induced neurogenesis. FASEB J. 2007, 21:2496-2509.
25. Krey G., Braissant O., L'Horset F., Kalkhoven E., Perroud M., Parker M.G., Wahli W. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 1997, 11:779-791.
26. Krezel W., Kastner P., Chambon P. Differential expression of retinoid receptors in the adult mouse central nervous system. Neuroscience 1999, 89:1291-1300.
27. Lane M.A., Bailey S.J. Role of retinoid signalling in the adult brain. Progr. Neurobiol. 2005, 75:275-293.
28. Latasa J.-J., Ituero M., Moran-González A., Aranda A., Cosgaya J.M. Retinoic acid regulates myelin formation in the peripheral nervous system. Glia 2010, 58:1451-1464.
29. Lengqvist J., Mata D.U., Bergman A.C., Willson T.M., Sjovall J., Perlmann T., Griffiths W.J. Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain. Mol. Cell Proteomics 2004, 3:692-703.
30. Liang Y., Lin S., Beyer T., Zhang Y., Wu X., Bales K.R., DeMattos R.B., May P.C., Li S.D., Jiang X.-C., Eacho P.I., Cao G., Paul S.M. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. J. Neurochem. 2005, 88:623-630.
31. Lovett-Racke A.E., Hussain R.Z., Northrop S., Choy J., Rocchini A., Matthes L., Chavis J.A., Diab A., Drew P.D., Racke M.K. Peroxisome proliferator-activated receptor α agonist as therapy for autoimmune disease. J. Immunol. 2004, 172:5790-5798.
32. Luo T., Wagner E., Grün F., Dräger U.C. Retinoic acid signaling in the brain marks formation of optic projections, maturation of the dorsal telencephalon, and function of limbic sites. J. Comp. Neurol. 2004, 470:297-316.
33. Mascrez B., Ghyselinck N.B., Watanabe M., Annicotte J.S., Chambon P., Auwerx J., Mark M. Ligand-dependent contribution of RXRbeta to cholesterol homeostasis in Sertoli cells. EMBO Rep. 2004, 5:285-290.
34. Massacesi L., Abbamondi A.L., Giorgi C., Sarlo F., Lolli F., Amaducci L. Suppression of experimental allergic encephalomyelitis by retinoic acid. J. Neurol. Sci. 1987, 80:55-64.
35. Massacesi L., Cstigli E., Vergelli M., Olivotto J., Abbamondi A.L., Sario F., Amaducci L. Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats. J. Clin. Invest. 1991, 88:1331-1337.
36. Matsushima G.K., Morell P. The neurotoxicant, Cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001, 11:107-116.
37. Mey J., McCaffery P. Retinoic acid signaling in the nervous system of adult vertebrates. Neuroscientist 2004, 10:409-421.
38. Mey J., McCaffery P., Klemeit M. Sources and sink of retinoic acid in the embryonic chick retina: distribution of aldehyde dehydrogenase activities, CRABP-I, and sites of retinoic acid inactivation. Dev. Brain Res. 2001, 127:135-148.
39. Mey J., Morassutti D., Brook G.A., Liu R.-H., Zhang Y.-P., Koopmans G., McCaffery P. Retinoic acid synthesis by a population of NG-2 positive cells in the injured spinal cord. Eur. J. Neurosci. 2005, 21:1555-1568.
40. Mey J., Schrage K., Wessels I., Vollpracht-Crijns I. Effects of inflammatory cytokines IL-1β, IL-6 and TNFα on the intracellular localization of retinoid receptors in Schwann cells. Glia 2007, 55:152-164.
41. Moreno S., Farioli-Vecchioli S., Cerù M.P. Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 2004, 123:131-145.
42. Na S.Y., Kim H.J., Lee S.K., Choi H.S., Na D.S., Lee M.O., Chung M., Moore D.D., Lee J.W. IkappaBbeta interacts with the retinoid X receptor and inhibits retinoid-dependent transactivation in lipopolysaccharide-treated cells. J. Biol. Chem. 1998, 273:3212-3215.
43. Natarajan C., Muthian G., Barak Y., Evans R.M., Bright J.J. Peroxisome proliferator-activated receptor-gamma-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis. J. Immunol. 2003, 171:5743-5750.
44. Niino M., Iwabuchi K., Kikuchi S., Ato M., Morohashi T., Ogata A., Tashiro K., Onoe K. Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma. J. Neuroimmunol. 2001, 116:40-48.
45. Paterniti I., Genovese T., Mazzon E., Crisafulli C., Di P.R., Galuppo M., Bramanti P., Cuzzocrea S. Liver X receptor agonist treatment regulates inflammatory response after spinal cord trauma. J. Neurochem. 2010, 112:611-624.
46. Polak P.E., Kalinin S., Dello R.C., Gavrilyuk V., Sharp A., Peters J.M., Richardson J., Willson T.M., Weinberg G., Feinstein D.L. Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2005, 168:65-75.
47. Poynter M.E., Daynes R.A. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J. Biol. Chem. 1998, 273:32833-32841.
48. Racke M.K., Burnett D., Pak S.H., Albert P.S., Cannella B., Raine C.S., McFarlin D.E., Scott D.E. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J. Immunol. 1995, 154:450-458.
49. Raikwar H.P., Muthian G., Rajasingh J., Johnson C.N., Bright J.J. PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2. J. Neuroimmunol. 2006, 178:76-86.
50. Rao V.L.R., Bowen K.K., Dhodda V.K., Song G., Franklin J.L., Gavva N.R., Dempsey R.J. Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal cerebral ischemia. J. Neurochem. 2002, 83:1072-1086.
51. Salvati S., Natali F., Attorri L., Di B.R., Leonardi F., Di B.A., Ferri F., Fortuna S., Lorenzini P., Sanchez M., Ricceri L., Vitelli L. Eicosapentaenoic acid stimulates the expression of myelin proteins in rat brain. J. Neurosci. Res. 2008, 86:776-784.
52. Schrage K., Koopmans G., Joosten E.A., Mey J. Macrophages and neurons are targets of retinoic acid signaling after spinal cord contusion injury. Eur. J. Neurosci. 2006, 23:285-295.
53. Schug T.T., Berry D.C., Shaw N.S., Travis S.N., Noy N. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 2007, 129:723-733.
54. Shearer K.D., Goodman T.H., Ross A.W., Reilly L., Morgan P.J., McCaffery P.J. Photoperiodic regulation of retinoic acid signaling in the hypothalamus. J. Neurochem. 2010, 112:246-257.
55. Torkildsen O., Brunborg L.A., Milde A.M., Mork S.J., Myhr K.M., Bo L. A salmon based diet protects mice from behavioural changes in the cuprizone model for demyelination. Clin. Nutr. 2009, 28:83-87.
56. Torkildsen O., Brunborg L.A., Thorsen F., Mork S.J., Stangel M., Myhr K.M., Bo L. Effects of dietary intervention on MRI activity, de- and remyelination in the cuprizone model for demyelination. Exp. Neurol. 2009, 215:160-166.
57. van Neerven S., Kampmann E., Mey J. RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases. Progr. Neurobiol. 2008, 85:433-451.
58. van Neerven S., Nemes A., Imholz P., Regen T., Denecke B., Johann S., Beyer C., Hanisch U.-K., Mey J. Inflammatory cytokine release of astrocytes in vitro is reduced by all-trans retinoic acid. J. Neuroimmunol. 2010, 229:169-179.
59. van Neerven S., Regen T., Wolf D., Nemes A., Johann S., Beyer C., Hanisch U.-K., Mey J. Inflammatory chemokine release of astrocytes in vitro is reduced by all-trans retinoic acid. J. Neurochem. 2010, 114:1511-1526.
60. Wang C., Kane M.A., Napoli J.L. Multiple retinol and retinal dehydrogenases catalyze all-trans-retinoic acid biosynthesis in astrocytes. J. Biol. Chem. 2011, 286:6542-6553.
61. Wang L., Schuster G.U., Hultenby K., Zhang Q., Andersson S., Gustafsson J.A. Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:13878-13883.
62. Xu J., Drew P.D. 9-cis-Retinoic acid suppresses inflammatory responses of microglia and astrocytes. J. Neuroimmunol. 2006, 171:135-144.
63. Young G., Conquer J. Omega-3 fatty acids and neuropsychiatric disorders. Reprod. Nutr. Dev. 2005, 45:1-28.
64. Zhang-Gandhi C.X., Drew P.D. Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes. J. Neuroimmunol. 2007, 183:50-59.
65. Zhao D., McCaffery P., Ivins K.J., Neve R.L., Hogan P., Chin W.W., Dräger U.C. Molecular identification of a major retinoic-acid-synthesizing enzyme, a retinaldehyde-specific dehydrogenase. Eur. J. Biochem. 1996, 240:15-22.
66. Zhelyaznik N., Mey J. Expression of retinoic acid receptors and retinoid X receptors after sciatic nerve injury. Neuroscience 2006, 141:1761-1774.
67. Zhelyaznik N., Schrage K., McCaffery P., Mey J. Activation of retinoic acid signaling after sciatic nerve injury: upregulation of cellular retinoid binding proteins. Eur. J. Neurosci. 2003, 18:1033-1040.